INS and glucose metabolism disease: Fourth, the central insulin signaling pathway is disrupted in patients with T2DM, and the impairment of insulin signaling can easily lead to a decrease in energy metabolism, specifically manifested in the decrease in ATP and glucose intake, the permeability and stability of nerve cells, and the negative impact of glucose metabolism disorders (Tamura et al., 2020).